IB Biology Quiz: Understand Enzymes And Metabolism
19 questions · exam conditions
0:00
Understand Enzymes And MetabolismQuestion 1 of 19

A newly discovered toxin binds to an enzyme at a site distinct from its active site. This binding event alters the tertiary structure of the enzyme, rendering the active site less effective at catalysing its reaction. The toxin cannot be displaced by adding more substrate. How should this toxin be classified?

As a competitive inhibitor.
As a non-competitive inhibitor.
As an irreversible denaturing agent.
As a substrate analogue.
← Back to quizzes

IB Biology Quiz

IB Biology Quiz: Understand Enzymes And Metabolism

Practice Understand Enzymes And Metabolism in IB Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Understand Enzymes And Metabolism, giving you a quick way to practice the rules, question types, and explanations that matter most for IB Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A newly discovered toxin binds to an enzyme at a site distinct from its active site. This binding event alters the tertiary structure of the enzyme, rendering the active site less effective at catalysing its reaction. The toxin cannot be displaced by adding more substrate. How should this toxin be classified?

  1. As a competitive inhibitor.
  2. As a non-competitive inhibitor. (correct answer)
  3. As an irreversible denaturing agent.
  4. As a substrate analogue.
Explanation: The toxin binds to an allosteric site (a site other than the active site) and changes the enzyme's conformation, which is the definition of non-competitive inhibition. The fact that its effect cannot be overcome by adding more substrate is a key characteristic that distinguishes it from competitive inhibition.

Question 2

In a metabolic pathway, substance P is converted to Q by Enzyme 1, Q to R by Enzyme 2, and R to S by Enzyme 3. Substance S acts as an allosteric inhibitor of Enzyme 1.

If substance S accumulates in the cell due to reduced demand, what will be the most immediate effect on the concentrations of the intermediates?

  1. The concentrations of both P and Q will increase.
  2. The concentration of P will increase while the concentration of Q will decrease. (correct answer)
  3. The concentrations of both Q and R will decrease.
  4. The concentration of R will increase while the concentration of S is stabilized.
Explanation: This describes end-product inhibition. The final product (S) inhibits the first enzyme (Enzyme 1). This stops the conversion of P to Q. As a result, the substrate for Enzyme 1 (P) will accumulate, while the product of Enzyme 1 (Q) will be produced at a lower rate and its concentration will decrease.

Question 3

Which statement best explains a key functional advantage of the induced fit model of enzyme-substrate interaction over the older lock-and-key model?

  1. It better explains the high degree of specificity between an enzyme and its substrate.
  2. It explains how the binding of the substrate can strain chemical bonds, lowering the activation energy. (correct answer)
  3. It explains why an enzyme's structure remains rigid and unchanged during the catalytic process.
  4. It proposes that the enzyme can bind to a wider range of different substrate molecules.
Explanation: The induced fit model proposes that the active site is flexible and changes shape upon substrate binding. This conformational change can contort the substrate molecule, straining its bonds and making them more susceptible to reaction. This process is a key part of how the enzyme lowers the activation energy, an aspect not well explained by the rigid lock-and-key model.

Question 4

Two experiments are conducted. In Experiment 1, reaction rate is measured at various substrate concentrations. In Experiment 2, the same is done but with a constant concentration of Inhibitor X. Results show that Vmax in Experiment 2 is lower than in Experiment 1, and this lower Vmax cannot be overcome by increasing substrate. What can be concluded about Inhibitor X?

  1. It is a competitive inhibitor.
  2. It is a non-competitive inhibitor. (correct answer)
  3. It causes permanent denaturation of the enzyme.
  4. It functions by binding covalently to the active site.
Explanation: A key feature of non-competitive inhibition is that it reduces the effective concentration of functional enzyme, thereby lowering the maximum possible reaction rate (Vmax). Since adding more substrate does not reverse this effect (as it would with competitive inhibition), the inhibitor must be non-competitive.

Question 5

Which statement provides the most accurate and comprehensive definition of metabolism?

  1. The process by which organisms break down complex molecules to release energy for cellular activities.
  2. The synthesis of complex macromolecules such as proteins and nucleic acids from simpler monomer units.
  3. The web of all enzyme-catalysed reactions in a cell or organism, including catabolic and anabolic pathways. (correct answer)
  4. The series of biochemical reactions that convert glucose into ATP in the presence of oxygen within mitochondria.
Explanation: Metabolism encompasses the totality of chemical reactions in a living organism. This includes both catabolism (breaking down molecules, as in choice A) and anabolism (building up molecules, as in choice B). Choice D describes only aerobic respiration, which is just one part of metabolism. Therefore, C is the most comprehensive definition.

Question 6

As temperature increases from a low value towards the optimum, the rate of an enzyme-catalysed reaction increases. However, beyond the optimum, the rate rapidly decreases. Which statement correctly explains both of these observations?

  1. Initially, increased kinetic energy leads to more frequent effective collisions; later, high temperatures disrupt weak bonds, causing denaturation. (correct answer)
  2. Initially, the enzyme gains activation energy from the heat; later, the substrate is completely destroyed by the high temperature.
  3. Initially, the enzyme's active site becomes more flexible and efficient; later, the enzyme runs out of available substrate.
  4. Initially, more substrate molecules bind to the active site per unit time; later, the accumulating product inhibits the enzyme's function.
Explanation: The effect of temperature is twofold. Up to the optimum, increasing temperature increases the kinetic energy of molecules, leading to more frequent and energetic collisions, thus increasing the reaction rate. Above the optimum, high thermal energy breaks the weak bonds (e.g., hydrogen bonds) that maintain the enzyme's specific tertiary structure. This denaturation changes the active site's shape, leading to a loss of activity.

Question 7

In many metabolic pathways, several enzymes are arranged into a multi-enzyme complex, where the product of the first enzyme is passed directly to the active site of the second. What is a primary metabolic advantage of such a complex?

  1. It increases the stability of the enzymes by protecting them from denaturation by changes in cytoplasmic conditions.
  2. It allows all the enzymes in the pathway to be regulated by a single allosteric inhibitor molecule binding to the complex.
  3. It prevents the diffusion of intermediate products away from the complex, increasing the efficiency of the overall pathway. (correct answer)
  4. It ensures that the overall reaction is exergonic by coupling individual endergonic steps to ATP hydrolysis.
Explanation: By channelling intermediates directly from one active site to the next, the cell prevents these molecules from diffusing into the cytoplasm. This maintains a high local concentration of the intermediates for the subsequent enzymes, prevents side reactions, and significantly increases the overall rate and efficiency of the pathway.

Question 8

Some inhibitors, like heavy metals, bind tightly to enzymes and permanently inactivate them. How does this type of irreversible inhibition typically differ from reversible non-competitive inhibition at a molecular level?

  1. Irreversible inhibitors form strong covalent bonds with the enzyme, while reversible inhibitors form weaker non-covalent interactions. (correct answer)
  2. Irreversible inhibitors always bind to the active site, whereas reversible inhibitors bind to an allosteric site.
  3. Irreversible inhibitors cause complete unfolding of the enzyme, while reversible inhibitors only alter the active site shape.
  4. Irreversible inhibitors are always large protein molecules, while reversible inhibitors are typically small organic molecules.
Explanation: The key difference lies in the bond type. Reversible inhibitors bind via weak interactions like hydrogen or ionic bonds, allowing them to dissociate. Irreversible inhibitors typically form stable, covalent bonds with amino acid side chains (often sulfhydryl groups), permanently modifying and inactivating the enzyme.

Question 9

Some multi-subunit enzymes exhibit cooperativity, where the binding of a substrate molecule to one active site increases the affinity of the other active sites for the substrate. This behaviour is a form of which type of regulation?

  1. Allosteric activation. (correct answer)
  2. Competitive inhibition.
  3. End-product inhibition.
  4. Irreversible denaturation.
Explanation: Cooperativity is a phenomenon where the binding of a ligand (in this case, the substrate) to one site on a protein affects the binding properties of other sites. Since the substrate binds to an active site but influences other active sites, it acts as an allosteric regulator. Because it increases affinity, it is a form of allosteric activation (where the substrate itself is the activator for the other subunits).

Question 10

Enzyme A has a Michaelis constant (Km) of 0.2 mM for its substrate, while Enzyme B has a Km of 2.0 mM for its substrate. Assuming both enzymes have the same Vmax, what can be deduced?

  1. Enzyme A will have a significantly higher maximum reaction rate than Enzyme B.
  2. Enzyme B has a higher affinity for its substrate and will be more efficient at low substrate concentrations.
  3. Enzyme B is likely a larger and more complex protein than Enzyme A.
  4. Enzyme A has a higher affinity for its substrate and will be more efficient at low substrate concentrations. (correct answer)
Explanation: The Michaelis constant, Km, is the substrate concentration at which the reaction rate is half of Vmax. A lower Km indicates that the enzyme has a higher affinity for its substrate, as it can reach half-maximal velocity at a lower substrate concentration. Therefore, Enzyme A is more efficient, especially when substrate levels are low.

Question 11

Which statement correctly describes the expected changes to the kinetic parameters Km (Michaelis constant) and Vmax (maximum velocity) in the presence of a competitive inhibitor versus a non-competitive inhibitor?

  1. Competitive: Km unchanged, Vmax unchanged. Non-competitive: Km unchanged, Vmax decreased.
  2. Competitive: Km unchanged, Vmax decreased. Non-competitive: increases apparent Km, Vmax unchanged.
  3. Competitive: increases apparent Km, Vmax decreased. Non-competitive: increases apparent Km, Vmax decreased.
  4. Competitive: increases apparent Km, Vmax unchanged. Non-competitive: Km unchanged, Vmax decreased. (correct answer)
Explanation: A competitive inhibitor competes for the active site, making the substrate appear less effective; thus, apparent Km increases, but Vmax can still be reached with enough substrate. A non-competitive inhibitor removes functional enzyme from the pool, lowering Vmax, but does not affect substrate binding to the remaining enzymes, so Km is unchanged.

Question 12

Both placing an enzyme in a solution with a pH of 2 and adding a non-competitive inhibitor can reduce its activity. Which statement best distinguishes the effects of these two treatments?

  1. The inhibitor's effect can be reversed by adding more substrate to the mixture, but the effect of the extreme pH cannot be reversed.
  2. The inhibitor denatures the enzyme by breaking its peptide bonds, while the extreme pH only blocks the active site from binding substrate.
  3. The extreme pH affects only the R-groups in the active site, whereas the inhibitor can bind anywhere on the enzyme's entire surface.
  4. The extreme pH causes irreversible denaturation via widespread bond disruption, while the inhibitor causes a specific, reversible conformational change. (correct answer)
Explanation: Extreme pH causes denaturation, a large-scale and often irreversible disruption of the ionic and hydrogen bonds maintaining the enzyme's tertiary structure. A non-competitive inhibitor typically binds to a specific allosteric site, causing a precise and usually reversible change in the active site's conformation. The key differences are the scale of the structural change (widespread vs. specific) and reversibility.

Question 13

A researcher suspects a substance is an enzyme inhibitor but does not know if it is competitive or non-competitive. Which experimental design would be most effective in distinguishing between the two types?

  1. Measure the reaction rate at a fixed, low substrate concentration while systematically varying the inhibitor concentration.
  2. Measure the reaction rate at a fixed inhibitor concentration while varying the substrate concentration over a wide range. (correct answer)
  3. Measure the reaction rate at different temperatures, both with and without a fixed concentration of the inhibitor present.
  4. Measure the reaction rate at a fixed substrate and inhibitor concentration, but at a range of different pH values.
Explanation: The key difference is how the inhibitors respond to changing substrate concentration. By measuring the rate at various substrate levels, one can determine if Vmax is affected. If the inhibition can be overcome at high substrate concentrations (i.e., Vmax is reachable), the inhibitor is competitive. If Vmax is lowered and cannot be reached, it is non-competitive.

Question 14

In an investigation into enzyme kinetics, the rate of reaction is observed to plateau and reach a maximum velocity (Vmax) even when more substrate is added. What is the primary limiting factor at this point?

  1. The concentration of available enzyme active sites. (correct answer)
  2. The initial concentration of the substrate in the reaction.
  3. The rate of product diffusion away from the active site.
  4. The kinetic energy of the substrate molecules.
Explanation: The reaction rate plateaus because the enzyme's active sites are saturated with substrate. At this point, the enzyme is working at its maximum capacity. The rate is limited by how quickly the enzyme can process the substrate and release the product (turnover rate), not by the availability of the substrate itself. Therefore, the concentration of active sites is the limiting factor.

Question 15

In a multi-step metabolic pathway, end-product inhibition typically involves the final product acting as an allosteric inhibitor of the first enzyme. What is the primary advantage of inhibiting the first step rather than a later step?

  1. The first enzyme is always the least stable and therefore the easiest to regulate through binding.
  2. It prevents the unnecessary synthesis and wasteful accumulation of intermediate products in the pathway. (correct answer)
  3. The final product's molecular shape is only complementary to the allosteric site of the first enzyme.
  4. Inhibiting the first step allows the final product to be rapidly degraded, preventing its toxic accumulation.
Explanation: By inhibiting the very first enzyme, the entire pathway is shut down efficiently. If a later enzyme were inhibited, all the intermediate substrates leading up to that step would continue to be produced and would accumulate. This is metabolically inefficient and wastes cellular resources and energy.

Question 16

How is allosteric regulation distinguished from the broader category of non-competitive inhibition?

  1. Allosteric regulators bind to the active site, whereas non-competitive inhibitors bind elsewhere.
  2. Allosteric regulation involves a conformational change in the enzyme, but non-competitive inhibition does not.
  3. Allosteric regulation can involve activation as well as inhibition, whereas non-competitive inhibition is exclusively inhibitory. (correct answer)
  4. Allosteric regulation is reversible, while non-competitive inhibition is always irreversible and permanent.
Explanation: Non-competitive inhibition is a type of allosteric regulation. However, the term 'allosteric regulation' is broader. It includes cases where a molecule (an allosteric activator) binds to the allosteric site and increases the enzyme's activity, in addition to cases of inhibition. Non-competitive inhibition, by definition, only refers to the reduction of enzyme activity.

Question 17

An enzyme normally functions in the human stomach. If this enzyme is moved to the small intestine, its activity drops to nearly zero. What is the most likely cause of this change in activity?

  1. The higher temperature in the small intestine causes permanent denaturation of the enzyme.
  2. The substrate for the enzyme is absent in the small intestine, preventing any reaction from occurring.
  3. The change from a highly acidic to a slightly alkaline environment alters the enzyme's structure and function. (correct answer)
  4. Competitive inhibitors present in the small intestine block the enzyme's active site completely.
Explanation: The stomach has a highly acidic environment (low pH), where enzymes like pepsin are optimally active. The small intestine has a slightly alkaline environment (higher pH). This significant change in pH would alter the ionization of the enzyme's amino acid R-groups, disrupting its tertiary structure and denaturing it, thus leading to a loss of activity.

Question 18

A significant deviation from an enzyme's optimal pH causes a sharp decrease in its catalytic activity. What is the primary molecular reason for this?

  1. The charge on amino acid R-groups is altered, disrupting the enzyme's tertiary structure and active site. (correct answer)
  2. The peptide bonds holding the primary structure of the enzyme are hydrolysed, breaking the polypeptide chain.
  3. The kinetic energy of the enzyme and substrate molecules is reduced, leading to fewer effective collisions.
  4. The substrate molecule is denatured by the acidic or alkaline conditions, preventing it from binding.
Explanation: pH affects the protonation state of acidic and basic R-groups of amino acids. Changes in these charges disrupt the ionic and hydrogen bonds maintaining the enzyme's specific three-dimensional structure. This change, particularly within the active site, impairs its ability to bind the substrate correctly and catalyse the reaction.

Question 19

The high specificity of an enzyme for its substrate is primarily determined by what factor?

  1. The sequence of amino acids forming the polypeptide chain (primary structure).
  2. The three-dimensional shape and chemical properties of the active site. (correct answer)
  3. The concentration of the enzyme relative to the substrate in the cellular environment.
  4. The presence of a specific coenzyme or inorganic cofactor required for the reaction.
Explanation: Enzyme specificity arises from the unique, complex three-dimensional conformation of its active site. While primary structure (A) determines this shape, it is the resulting 3D structure and the chemical nature of the R-groups within the active site that are directly responsible for recognizing and binding the specific substrate.